BML Capital Management »

Ikena Oncology shares owned by BML Capital Management

Quarter-by-quarter ownership of Ikena Oncology (IKNA) shares owned by BML Capital Management from 13F filings

Historical chart of BML Capital Management investment in Ikena Oncology

Tip: Access up to 7 years of quarterly data

All positions including Ikena Oncology held by BML Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ikena Oncology by BML Capital Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $965k 585k 1.65

More positions owned by BML Capital Management

Ishares Tr 0-3 Mnth Treasry (SGOV)
Atea Pharmaceuticals (AVIR)
Spdr Ser Tr Bloomberg 1-3 Mo (BIL)
Aclaris Therapeutics (ACRS)
Adverum Biotechnologies Com New (ADVM)
Tectonic Therapeutic (TECX)
Reneo Pharmaceuticals (RPHM)
Instil Bio Com New (TIL)
Wingstop Put Option (WING)
Oramed Pharmaceuticals Com New (ORMP)
Connect Biopharma Hldgs Ads (CNTB)
Athira Pharma (ATHA)
Vanda Pharmaceuticals (VNDA)
Pmv Pharmaceuticals (PMVP)
Astrotech Corp (ASTC)

View all positions for BML Capital Management

Top funds holding Ikena Oncology

Atlas Venture Life Science Advisors
BVF
Blue Owl Capital Holdings
OrbiMed Advisors
Omega Fund Management
Vanguard Group
BML Capital Management
NEA Management Company
Renaissance Technologies
Jacobs Levy Equity Management
Acuitas Investments
Sofinnova Ventures
BlackRock
Millennium Management
Acadian Asset Management

View all funds holding Ikena Oncology